Flixotide Evohaler is a prescription inhaler containing 125 micrograms of fluticasone propionate per actuation. Manufactured by GlaxoSmithKline, this metered-dose inhaler provides 60 doses of medication for the treatment of asthma and other respiratory conditions. This is a prescription-only medication that must be used under medical supervision. The inhaler delivers a precise 125mcg dose of fluticasone propionate with each actuation through a metered-dose mechanism. The product should be stored at room temperature and kept out of reach of children. Shake well before each use.